The product is Pathfinder SL, version 1.6.0.3057 software used with the Spacelabs Healthcare Path...

FDA Device Recall #Z-1831-2012 — Class II — May 11, 2012

Recall Summary

Recall Number Z-1831-2012
Classification Class II — Moderate risk
Date Initiated May 11, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Spacelabs Healthcare, Llc
Location Issaquah, WA
Product Type Devices
Quantity 114

Product Description

The product is Pathfinder SL, version 1.6.0.3057 software used with the Spacelabs Healthcare Pathfinder SL Holter Analyzer, version 1.6.0. Product Usage: The Holter Analyzer analyzes information collected from ambulatory electrocardiogram recorders worn by patients and used to assist physicians in diagnosis and patient monitoring. In addition, incorrect QTc values are reported after moving the cursor. QTc values are timing events between labeled points of interest in the ECG signal that the physician can mark with the cursor. The software is used to edit a family of events and upon conclusion the software crashes with an error message.

Reason for Recall

The firm received reports of the Pathfinder LS software crashing after editing a batch of Holter Analyzer records. The software will stop with an error message requiring a restart. In addition, QTc values will not update after moving the marker.

Distribution Pattern

Worldwide Distribution - US (nationwide) including the states of Nevada and Vermont, and the countries of AUSTRALIA, AUSTRIA, CANADA, CYPRUS, GERMANY, ICELAND, ISRAEL, POLAND, ROMANIA, SOUTH AFRICA, SWITZERLAND, THAILAND, TURKEY and UNITED KINGDOM.

Lot / Code Information

Version 1.6.0.

Other Recalls from Spacelabs Healthcare, Llc

Recall # Classification Product Date
Z-1273-2014 Class II Spacelabs Healthcare G2 Clinical Access Mislabe... Feb 14, 2014
Z-0871-2014 Class II ARIATELE TELEMETRY TRANSMITTER, Model 96281, wi... Dec 19, 2013
Z-0351-2014 Class II Spacelabs Healthcare qube Compact Patient Monit... Oct 17, 2013
Z-0188-2014 Class II Spacelabs Healthcare elance Vital Signs Monitor... Oct 17, 2013
Z-0694-2013 Class II Spacelabs Smart Disclosure System, Model 92810,... Dec 5, 2012

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.